Now, 18 years later, after suffering from cervical cancer, secondary lung cancer, and treatment-related myelodysplasia, she is alive, well, and cancer-free. McLelland had repeatedly been told that diet had no impact on cancer, but the fact that her lung tumor had remained the size of a golf ball—and the fact that there were no tumors in other locations in her body—proved to her that the dietary changes she had already made were making a difference. In her book, McLelland provides all the information a cancer patient might need to point them in the right direction for developing a protocol to starve their cancer. The Metro Map is the key to starving the cancer. Once you’ve done that, killing it becomes much easier,” said McLelland. Now, 18 years after her initial cancer diagnosis—after battling cervical, lung, and blood cancers—McLelland is living the life of her dreams. She married the love of her life, and through the selflessness of a surrogate, was able to have two sons of her own.

McLelland believed she had finally found out how to beat her cancer once and for all. And her test results proved her right. Blood tests revealed that her TM2PK tumor markers (a marker of abnormal glycolysis) had dropped from 397 to 21.5—just slightly above a “normal” reading of 15. Galima bandyti argumentuoti, kad čia tik vienas atvejis, kad nežinia dėl ko pavyko pasveikti, kad už pasveikimą atsakinga chemoterapija, o ne tie magiški vaistai. Visi šie punktai turi pagrindą. Tačiau lieka dar vienas didelis BET. Jane yra tokia gan konkreti ir ne iš kelmo spirta moteriškė, ir visą savo gydymo eigą, visus vaistus ir papildus ji kruopščiai research'ino. To rezultatas yra daugiau nei 250 nuorodų į atliktus tyrimus, ir rašydamas "tyrimus", aš turiu omeny tuos "tikrus" tyrimus, peer reviewed and published stiliaus tyrimus, kuriuos visus kiekvienas norintis gali susirasti tokiuose kuklučiuose saituose kaip NCBI, PubMed, International Journal of Oncology ir taip toliau. The first big gun was a cardiovascular drug called dipyridamole, which stops protein from getting into the cancer cell, a key factor in starving leukemia, according to McLelland.

Starving Cancer

I already knew that statins would be potentially useful against cervical cancer. But research had also shown that they caused apoptosis in acute myeloid leukemias. I also had overlooked the fact that NSAIDs could cause cell death (apoptosis),” said McLelland. “What I learned from the Life Extension article was that there was a synergy between the two drugs, making them far more potent when taken together.” Her diet and numerous supplements were already helping on that front—particularly berberine, hydroxycitrate, gymnema, curcumin, niacin, and pycnogenol—all of which were inhibiting key pathways that are abnormal in cancer. She also underwent treatment with high-dose intravenous vitamin C. McLelland created a diagram depicting her approach to starving cancer that she calls the “Metro Map,” based on an analogy of an underground metro system. While the sugar-and-insulin angle has shown promise, more of the research has focused on dietary protein—or, specifically, individual amino acids that make up that protein. Studies have shown that the restriction of the amino acids serine and glycine can modulate cancer outcomes. According to a 2018 study in Nature, the chemotherapy drug methotrexate is affected by the amino acid histidine. Another, asparagine, is involved in the progression of breast cancer metastasis. Suggesting that people fast or starve themselves to kill a tumor has been the domain of dubious and exaggerated claims over the years, and that is not the suggestion now. In recent trials, metabolic pathways have been targeted though various approaches to changing what people eat. Some research has involved minimizing sugar intake. Indeed, some cancer cells metabolize glucose at higher than normal levels (to support the process of aerobic glycolysis), and depleting their access to sugar can slow growth.

This book will answer all the burning questions you face when you begin to explore integrative treatments. Which ‘off-label’ drugs and supplements should you take? Should you try the ketogenic diet? Should you fast? Is fat safe? How much and when should you exercise? Jane explains why each patient needs a personalised approach and, importantly, how to work this out.This strategy could be applied beyond rare sarcoma tumors because the metabolic defect is often present in other cancers, including certain types of breast, colon, lung, brain and bone tumors, the researchers said. The new study includes data showing similar anti-tumor responses in cell lines from these cancer types. Van Tine also pointed out that all of the drugs used in the study are either already approved by the U.S. Food and Drug Administration for other conditions or in ongoing clinical trials investigating cancer drugs. That’s, uh, yeah,” he attempted to patiently explain. “It’s basically saying we can quantify what’s happening in the cells.” Jane McLelland McLelland was reluctant about writing her book, but she felt she had a duty to share with the world what she had discovered—and what had saved her life.

However, McLelland cautions that there is no one-size-fits-all approach. Her own experience with her various forms of cancer highlight that fact. Instead, McLelland’s approach focuses on learning which fuel sources your particular cancer uses—and then creating a targeted treatment plan based on that information.I couldn’t understand why I was controlling one cancer without controlling the other,” said McLelland. “But it’s all about metabolism. The metabolism of my leukemia was totally different from that of my cervical cancer. So, with my low glycemic index diet, I was controlling the cervical cancer, but I wasn’t controlling the leukemia, which instead thrives on proteins.” STARS! I'm in tears. I just finished chapter 19 of this book. I just love Jane! I love her. Her ❤️, her tenacity in the face of crazy levels of difficulty, and her desire to share!!

This book will answer all the burning questions you face when you begin to explore complementary cancer care. Which 'off-label' drugs and supplements should you take? Should you try the ketogenic diet? Should you fast? Is fat safe? How much and when should you exercise? Jane explains why each patient needs a personalised approach and, importantly, how to work this out. McLelland underwent surgery to remove the tumor in her lung, and she endured six months of chemo (at a much lower dose than that recommended by her oncologist). But this time, she also employed a strategy to starve the cancer’s stem cells. But McLelland refused to go down without a fight. Taking matters into her own hands, she dug through medical journals, poring over long-forgotten research and overlooked evidence, looking for clues to overcoming her cancer.Now doctors are starting to think more about specific nutrients that feed tumor cells. That is, how what we eat affects how cancers grow—and whether there are ways to potentially “starve” cancer cells without leaving a person undernourished, or even hungry. I do believe we already have every drug and every supplement that we need to beat cancer. The key is getting the right combinations to people at the right time,” said McLelland. “Yes, in certain circumstances there can be too much damage to the body from the cancer itself. But if you can get to people before that, I cannot see why patients can’t be rescued even from advanced malignancies. Stage IV cancer should not be a death sentence, in my view.”